Evidence map›Paper›PMID 35745000›Full record

ArticleMolecules (Basel, Switzerland)2022

Synergistic Anti-Inflammatory Activity of Ginger and Turmeric Extracts in Inhibiting Lipopolysaccharide and Interferon-γ-Induced Proinflammatory Mediators.

Xian Zhou, Sualiha Afzal, Hans Wohlmuth, Gerald Münch, David Leach, Mitchell Low, Chun Guang Li

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Local Delivery of Ginger ExtractCurrent drug delivery · 2026
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Combination of Nicotinamide andPreventive nutrition and food science · 2024
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. The Effectiveness ofVascular health and risk management · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xian ZhouNICM Health Research Institute, Western Sydney University, Westmead, NSW 2145, Australia.ORCID 0000-0001-8766-8158
Sualiha AfzalPharmacology Unit, School of Medicine, Western Sydney University, Narellan Road & Gilchrist Drive, Campbelltown, NSW 2560, Australia.
Hans WohlmuthNICM Health Research Institute, Western Sydney University, Westmead, NSW 2145, Australia.
Gerald MünchPharmacology Unit, School of Medicine, Western Sydney University, Narellan Road & Gilchrist Drive, Campbelltown, NSW 2560, Australia.
David LeachIntegria Healthcare, 2728 Logan Road, Brisbane, QLD 4113, Australia.
Mitchell LowNICM Health Research Institute, Western Sydney University, Westmead, NSW 2145, Australia.ORCID 0000-0003-2021-1924
Chun Guang LiNICM Health Research Institute, Western Sydney University, Westmead, NSW 2145, Australia.
Western Sydney University · AUThe University of Queensland · AU

Funding

Australian Research Council LP160101594
6 · The paper itself

Abstract

This study aims to investigate the combined anti-inflammatory activity of ginger and turmeric extracts. By comparing the activities of individual and combined extracts in lipopolysaccharide and interferon-γ-induced murine RAW 264.7 cells, we demonstrated that ginger-turmeric combination was optimal at a specific ratio (5:2, w/w) in inhibiting nitric oxide, tumour necrosis factor and interleukin 6 with synergistic interaction (combination index < 1). The synergistic inhibitory effect on TNF was confirmed in human monocyte THP-1 cells. Ginger-turmeric combination (5:2, w/w) also upregulated nuclear factor erythroid 2−related factor 2 activity and heme oxygenase-1 protein expression. Additionally, 6-shogaol, 8-shogaol, 10-shogaol and curcumin were the leading compounds in reducing major proinflammatory mediators and cytokines, and a simplified compound combination of 6-s, 10-s and curcumin showed the greatest potency in reducing LPS-induced NO production. Our study provides scientific evidence in support of the combined use of ginger and turmeric to alleviate inflammatory processes.

Indexed as

CurcuminZingiber officinaleAnimalsAnti-Inflammatory AgentsCurcumaHeme Oxygenase-1HumansInterferon-gammaLipopolysaccharidesMiceNF-E2-Related Factor 2Plant ExtractsAnti-Inflammatory AgentsCurcuminHeme Oxygenase-1Interferon-gammaLipopolysaccharidesNF-E2-Related Factor 2Plant Extractsanti-inflammatorycombination indexgingerNrf2-HO-1synergyturmeric

Identifiers

PMID35745000
PMCPMC9229778
OpenAlexW4283021433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.